Bilateral Thalamic Lesions Associated With Atezolizumab-Induced Autoimmune Encephalitis

Neurology. 2021 Jan 19;96(3):126-127. doi: 10.1212/WNL.0000000000011297. Epub 2020 Dec 2.

Authors

Haruo Nishijima¹, Chieko Suzuki², Tomoya Kon², Takashi Nakamura², Hisashi Tanaka², Yui Sakamoto², Masahiko Tomiyama²

Affiliations

¹ From the Department of Neurology, Institute of Brain Science (H.N., C.S., T.K., T.N., M.T.), Department of Respiratory Medicine (H.T.), and Department of Neuropsychiatry (Y.S.), Hirosaki University Graduate School of Medicine; and Department of Neurology (H.N.), Hirosaki University Hospital, Hirosaki City, Aomori, Japan. hnishijima-tky@umin.ac.jp.
² From the Department of Neurology, Institute of Brain Science (H.N., C.S., T.K., T.N., M.T.), Department of Respiratory Medicine (H.T.), and Department of Neuropsychiatry (Y.S.), Hirosaki University Graduate School of Medicine; and Department of Neurology (H.N.), Hirosaki University Hospital, Hirosaki City, Aomori, Japan.

PMID: 33268558
DOI: 10.1212/WNL.0000000000011297

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Carcinoma, Non-Small-Cell Lung / drug therapy
Encephalitis / chemically induced*
Encephalitis / diagnostic imaging
Encephalitis / drug therapy
Female
Glucocorticoids / therapeutic use
Hashimoto Disease / chemically induced*
Hashimoto Disease / diagnostic imaging
Hashimoto Disease / drug therapy
Humans
Immunoglobulins, Intravenous / therapeutic use
Lung Neoplasms / drug therapy
Magnetic Resonance Imaging
Thalamus / diagnostic imaging*
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Glucocorticoids
Immunoglobulins, Intravenous
atezolizumab

Supplementary concepts

Hashimoto's encephalitis